Anti-CTH monoclonal antibody

Pre-made anti-CTH monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CTH/CTH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T12241-Ab-1/ GM-Tg-hg-T12241-Ab-2Anti-Human CTH monoclonal antibodyHuman
GM-Tg-rg-T12241-Ab-1/ GM-Tg-rg-T12241-Ab-2Anti-Rat CTH monoclonal antibodyRat
GM-Tg-mg-T12241-Ab-1/ GM-Tg-mg-T12241-Ab-2Anti-Mouse CTH monoclonal antibodyMouse
GM-Tg-cynog-T12241-Ab-1/ GM-Tg-cynog-T12241-Ab-2Anti-Cynomolgus/ Rhesus macaque CTH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T12241-Ab-1/ GM-Tg-felg-T12241-Ab-2Anti-Feline CTH monoclonal antibodyFeline
GM-Tg-cang-T12241-Ab-1/ GM-Tg-cang-T12241-Ab-2Anti-Canine CTH monoclonal antibodyCanine
GM-Tg-bovg-T12241-Ab-1/ GM-Tg-bovg-T12241-Ab-2Anti-Bovine CTH monoclonal antibodyBovine
GM-Tg-equg-T12241-Ab-1/ GM-Tg-equg-T12241-Ab-2Anti-Equine CTH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T12241-Ab-1/ GM-Tg-hg-T12241-Ab-2; GM-Tg-rg-T12241-Ab-1/ GM-Tg-rg-T12241-Ab-2;
GM-Tg-mg-T12241-Ab-1/ GM-Tg-mg-T12241-Ab-2; GM-Tg-cynog-T12241-Ab-1/ GM-Tg-cynog-T12241-Ab-2;
GM-Tg-felg-T12241-Ab-1/ GM-Tg-felg-T12241-Ab-2; GM-Tg-cang-T12241-Ab-1/ GM-Tg-cang-T12241-Ab-2;
GM-Tg-bovg-T12241-Ab-1/ GM-Tg-bovg-T12241-Ab-2; GM-Tg-equg-T12241-Ab-1/ GM-Tg-equg-T12241-Ab-2
Products NameAnti-CTH monoclonal antibody
Formatmab
Target NameCTH
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CTH monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T12241-Ag-1Recombinant multi-species CGL/ CTH protein
    ORF Viral VectorpGMLV000312human CTH Lentivirus plasmid
    ORF Viral VectorvGMLV000312human CTH Lentivirus particle
    ORF Viral VectorpGMLPm002075mouse Cth Lentivirus plasmid
    ORF Viral VectorvGMLPm002075mouse Cth Lentivirus particle


    Target information

    Target IDGM-T12241
    Target NameCTH
    Gene ID1491,107869,24962,696664,479991,101083282,539159,100053614
    Gene Symbol and Synonyms0610010I13Rik,CGL,CSE,CTH,Cys3
    Uniprot AccessionP32929,P18757,Q58DW2
    Uniprot Entry NameCGL_HUMAN,CGL_RAT,CGL_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000116761
    Target ClassificationN/A

    The target: CTH, gene name: CTH, also named as . This gene encodes a cytoplasmic enzyme in the trans-sulfuration pathway that converts cystathione derived from methionine into cysteine. Glutathione synthesis in the liver is dependent upon the availability of cysteine. Mutations in this gene cause cystathioninuria. Alternative splicing of this gene results in three transcript variants encoding different isoforms. [provided by RefSeq, Jun 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.